SecBot SecBot
SC 13G ·Filed Oct 23, 2026

ACET

Adicet Bio, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 12h ago SEC0002161951-26-000001
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future conversion of this 13G to a 13D, which would signal activist intent. Otherwise, this is a routine passive disclosure with no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Daniel Clayton Zedek and Lauren Marie Zedek filed a Schedule 13G on October 23, 2026, disclosing aggregate beneficial ownership of 502,309 shares of Adicet Bio, Inc. common stock, representing 5.4% of shares outstanding. This is a new passive stake filing with no intent to influence control, and the filing does not provide any financial data or material corporate events.

Key Financial Metrics

Stake
5.4%
Investor
Daniel Clayton Zedek and Lauren Marie Zedek

Key Facts

  • Daniel Clayton Zedek and Lauren Marie Zedek filed a new Schedule 13G on October 23, 2026.
  • Aggregate beneficial ownership: 502,309 shares of common stock.
  • Percentage of shares outstanding: 5.4%.
  • The filing certifies the shares were not acquired to change or influence control of the issuer.
  • The filing is passive (Rule 13d-1(c)) with no activist intent.
  • A prior SC 13G/A by Tang Capital Management was filed on February 17, 2026, but no stake details are available from that filing.

Financial Impact

No financial impact — passive 5.4% stake disclosure with no material financial data.

Risk Factors

  • No material risks identified from this passive filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0002161951-26-000001
Document: 0002161951-26-000001-index-headers.html0002161951-26-000001
Document: 0002161951-26-000001-index.html0002161951-26-000001
Document: 0002161951-26-000001.txt0002161951-26-000001
8 reports for ACET
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ACET — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
SC 13G
NEUTRAL ★ 3/10
$4.03awaiting T+20—$3.93 (−2.47%)
Sep 28, 2026
29d ago
8-K
BULLISH ★ 7/10
$6.35 $3.94▼ −37.95%▼ −37.92%$3.93 (−38.11%)
Sep 1, 2026
8w ago
8-K
NEUTRAL ★ 5/10
$9.26 $7.12▼ −23.11%▼ −24.29%$3.93 (−57.56%)
May 20, 2026
22w ago
10-K/A
NEUTRAL ★ 2/10
$7.89 $8.23▲ +4.31%▲ +3.98%$3.93 (−50.19%)
May 13, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$8.41 $8.05▼ −4.28%▼ −3.42%$3.93 (−53.27%)
Apr 8, 2026
28w ago
144
NEUTRAL ★ 3/10
$6.86 $8.55▲ +24.64%▲ +17.07%$3.93 (−42.71%)
Apr 7, 2026
28w ago
144
NEUTRAL ★ 3/10
$6.55 $8.51▲ +29.92%▲ +21.38%$3.93 (−40.00%)
Mar 24, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
$6.69 $8.31▲ +24.22%▲ +15.31%$3.93 (−41.26%)
Showing 8 of 8

US Market Status

Market Open — Closes in 6h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 23, 2026